Direct in vivo reprogramming to relieve tissue ischemia via induced vasculogenesis

There is an ongoing need for innovative cell and regenerative medicine therapies to promote vascular repair and regeneration to meet the growing global health concern of ischemic cardiovascular diseases. Direct reprogramming of somatic cells into an induced pluripotent state caused scientists to rec...

Full description

Saved in:
Bibliographic Details
Published in:Molecular therapy Vol. 33; no. 11; p. 5338
Main Authors: Yoder, Mervin C, Sen, Chandan K
Format: Journal Article
Language:English
Published: United States 05.11.2025
Subjects:
Animals
Cell Differentiation
Cellular Reprogramming
Endothelial Cells - cytology
Endothelial Cells - metabolism
Fibroblasts - cytology
Fibroblasts - metabolism
Humans
Induced Pluripotent Stem Cells - cytology
Induced Pluripotent Stem Cells - metabolism
Ischemia - metabolism
Ischemia - therapy
Neovascularization, Physiologic
Regenerative Medicine - methods
in vivo reprogramming
wound
vasculogenic fibroblast
regenerative medicine
tissue nanotransfection
ISSN:1525-0024, 1525-0024
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:There is an ongoing need for innovative cell and regenerative medicine therapies to promote vascular repair and regeneration to meet the growing global health concern of ischemic cardiovascular diseases. Direct reprogramming of somatic cells into an induced pluripotent state caused scientists to reconsider prior theories of cell differentiation and develop approaches to directly reprogram cells in vivo into other states or fates to adaptively replace cells lost to aging or disease. While direct in vivo reprogramming of fibroblast to cardiomyocytes, neurons, or pancreatic beta islet cell states has been studied since 2008, direct in vivo reprogramming of fibroblasts into induced vasculogenic cells was not reported until 2017. This review provides a brief overview of the field of in vitro direct reprogramming of fibroblasts into induced endothelial cells over the past decade and identifies key similarities and differences in approaches. The primary focus of this review is to discuss in detail 4 published reports of direct in vivo reprogramming of fibroblasts into vasculogenic cell states and identify a series of questions for future studies that will clarify the reprogrammed cells and potential for using these approaches for translation into larger preclinical models or human subjects.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1525-0024
1525-0024
DOI:10.1016/j.ymthe.2025.08.013